• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-154 通过靶向 HMGA2 抑制前列腺癌细胞中的 EMT。

miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cells.

机构信息

State Key Laboratory of Reproductive Medicine, Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

出版信息

Mol Cell Biochem. 2013 Jul;379(1-2):69-75. doi: 10.1007/s11010-013-1628-4. Epub 2013 Apr 17.

DOI:10.1007/s11010-013-1628-4
PMID:23591597
Abstract

Epithelial-mesenchymal transition (EMT) is a crucial process that plays an important role in the invasion and metastasis of human cancers. High-mobility group AT-hook 2 (HMGA2) has been found to be involved in the EMT program, with its aberrant expression having been observed in a variety of malignant tumors. However, the mechanisms regulating HMGA2 expression remain incompletely understood. The objective of this study was to investigate whether mir-154 plays a critical role in EMT by regulating HMGA2. The expression levels of HMGA2 were examined in four samples of prostate cancer (PCa) tissue and adjacent non-tumorous tissue by Western blot analysis. The effects of forced expression of miR-154 or HMGA2 knockdown on PCa cells were evaluated by cell migration and invasion assays and Western blot analysis. HMGA2 was upregulated in the PCa tissue samples compared with the adjacent normal ones. Forced expression of miR-154 or HMGA2 knockdown significantly reduced the migratory and invasive capabilities of PCa cells in vitro and inhibited EMT gene expression, increased the levels of E-cadherin, an epithelial marker, and decreased the levels of vimentin, a mesenchymal marker. HMGA2 is a direct target gene of miR-154 by dual-luciferase reporter assay. Our findings suggest that miR-154 plays a role in regulating EMT by targeting HMGA2. Understanding the targets and regulating pathways of miR-154 may provide new insights into the underlying pathogenesis of PCa.

摘要

上皮-间质转化(EMT)是一个重要的过程,在人类癌症的侵袭和转移中起着重要作用。高迁移率族 AT 钩 2(HMGA2)已被发现参与 EMT 程序,其异常表达已在多种恶性肿瘤中观察到。然而,调节 HMGA2 表达的机制仍不完全清楚。本研究旨在探讨 mir-154 是否通过调节 HMGA2 在 EMT 中发挥关键作用。通过 Western blot 分析检测了 4 例前列腺癌(PCa)组织和相邻非肿瘤组织中 HMGA2 的表达水平。通过细胞迁移和侵袭实验以及 Western blot 分析评估了强制表达 miR-154 或 HMGA2 敲低对 PCa 细胞的影响。与相邻正常组织相比,PCa 组织样本中 HMGA2 上调。强制表达 miR-154 或 HMGA2 敲低显著降低了 PCa 细胞在体外的迁移和侵袭能力,并抑制了 EMT 基因表达,增加了上皮标志物 E-钙粘蛋白的水平,降低了间充质标志物波形蛋白的水平。双荧光素酶报告基因检测显示 HMGA2 是 miR-154 的直接靶基因。我们的研究结果表明,miR-154 通过靶向 HMGA2 在 EMT 中发挥作用。了解 miR-154 的靶标和调节途径可能为深入了解 PCa 的发病机制提供新的思路。

相似文献

1
miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cells.miR-154 通过靶向 HMGA2 抑制前列腺癌细胞中的 EMT。
Mol Cell Biochem. 2013 Jul;379(1-2):69-75. doi: 10.1007/s11010-013-1628-4. Epub 2013 Apr 17.
2
Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.Let-7a通过靶向鼻咽癌中的HMGA2抑制迁移、侵袭和上皮-间质转化。
J Transl Med. 2015 Mar 31;13:105. doi: 10.1186/s12967-015-0462-8.
3
[miR-let-7c-5p inhibits invasion and migration of bladder cancer cells by targeting HMGA2].[微小RNA-let-7c-5p通过靶向高迁移率族蛋白A2抑制膀胱癌细胞的侵袭和迁移]
Nan Fang Yi Ke Da Xue Xue Bao. 2021 Jul 20;41(7):1022-1029. doi: 10.12122/j.issn.1673-4254.2021.07.08.
4
MicroRNA-495 Inhibits Gastric Cancer Cell Migration and Invasion Possibly via Targeting High Mobility Group AT-Hook 2 (HMGA2).微小RNA-495可能通过靶向高迁移率族AT-钩蛋白2(HMGA2)抑制胃癌细胞的迁移和侵袭。
Med Sci Monit. 2017 Feb 4;23:640-648. doi: 10.12659/msm.898740.
5
Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.长链非编码 RNA HOTTIP 下调通过 HMGA2 介导的 Wnt/β-连环蛋白通路抑制口腔舌鳞癌细胞的增殖、迁移和侵袭。
Cancer Biother Radiopharm. 2020 Nov;35(9):720-730. doi: 10.1089/cbr.2019.3017. Epub 2020 Jan 8.
6
Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.下调HMGA2可减弱鼻咽癌细胞中上皮-间质转化诱导的侵袭和迁移。
Biochem Biophys Res Commun. 2015 Jul 31;463(3):357-63. doi: 10.1016/j.bbrc.2015.05.068. Epub 2015 May 27.
7
MiR-219-5p inhibits prostate cancer cell growth and metastasis by targeting HMGA2.miR-219-5p 通过靶向 HMGA2 抑制前列腺癌细胞生长和转移。
Eur Rev Med Pharmacol Sci. 2020 May;24(9):4710-4718. doi: 10.26355/eurrev_202005_21159.
8
LncRNA LINC00355 promotes EMT and metastasis of bladder cancer cells through the miR-424-5p/HMGA2 axis.长链非编码 RNA LINC00355 通过 miR-424-5p/HMGA2 轴促进膀胱癌细胞的 EMT 和转移。
Neoplasma. 2021 Nov;68(6):1225-1235. doi: 10.4149/neo_2021_210427N574. Epub 2021 Oct 10.
9
miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.miR-302a-5p/367-3p-HMGA2 轴调控子宫内膜癌发展过程中的恶性进程。
J Exp Clin Cancer Res. 2018 Feb 1;37(1):19. doi: 10.1186/s13046-018-0686-6.
10
microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer.微小RNA-802通过靶向人前列腺癌中的 flotillin-2抑制上皮-间质转化
Biosci Rep. 2017 Mar 15;37(2). doi: 10.1042/BSR20160521. Print 2017 Apr 30.

引用本文的文献

1
miRNA-mediated resistance mechanisms in prostate cancer: implications for targeted therapy and metastatic progression.前列腺癌中微小RNA介导的耐药机制:对靶向治疗和转移进展的影响
Med Oncol. 2025 Aug 29;42(10):454. doi: 10.1007/s12032-025-03006-7.
2
Dysregulation of TCONS_00006091 contributes to the elevated risk of oral squamous cell carcinoma by upregulating SNAI1, IRS and HMGA2.TCONS_00006091 的失调通过上调 SNAI1、IRS 和 HMGA2 导致口腔鳞状细胞癌风险升高。
Sci Rep. 2024 Apr 26;14(1):9616. doi: 10.1038/s41598-024-60310-4.
3
HMGA2 promotes cancer metastasis by regulating epithelial-mesenchymal transition.

本文引用的文献

1
miR-154 inhibits prostate cancer cell proliferation by targeting CCND2.miR-154 通过靶向 CCND2 抑制前列腺癌细胞增殖。
Urol Oncol. 2014 Jan;32(1):31.e9-16. doi: 10.1016/j.urolonc.2012.11.013. Epub 2013 Feb 19.
2
HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases.HMGA2 蛋白在卵巢浆液性癌性渗出液、原发肿瘤和实体转移中的表达。
Virchows Arch. 2012 May;460(5):505-13. doi: 10.1007/s00428-012-1228-9. Epub 2012 Apr 4.
3
MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms.
HMGA2通过调节上皮-间质转化促进癌症转移。
Front Oncol. 2024 Feb 1;14:1320887. doi: 10.3389/fonc.2024.1320887. eCollection 2024.
4
Antiproliferative effects of dried Moringa oleifera leaf extract on human Wharton's Jelly mesenchymal stem cells.辣木叶干提取物对人牙髓间充质干细胞的抗增殖作用。
PLoS One. 2022 Oct 5;17(10):e0274814. doi: 10.1371/journal.pone.0274814. eCollection 2022.
5
Preliminary construction of a regulatory network of miRNAs in the pathogenesis of nucleus pulposus degeneration - a review based on data mining.基于数据挖掘的髓核退变发病机制中miRNA调控网络的初步构建——综述
Am J Transl Res. 2021 Sep 15;13(9):9919-9931. eCollection 2021.
6
miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer.微小RNA作为前列腺癌的治疗工具和生物标志物
Pharmaceutics. 2021 Mar 13;13(3):380. doi: 10.3390/pharmaceutics13030380.
7
HMGA2 as a Critical Regulator in Cancer Development.HMGA2 作为癌症发展中的关键调控因子。
Genes (Basel). 2021 Feb 13;12(2):269. doi: 10.3390/genes12020269.
8
MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers.微小RNA-154:人类癌症诊断与治疗的新候选者。
Onco Targets Ther. 2020 Jul 7;13:6603-6615. doi: 10.2147/OTT.S249268. eCollection 2020.
9
microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation.前列腺癌中的 microRNAs:对电离辐射反应的相关性研究。
Mol Cancer. 2020 Mar 23;19(1):63. doi: 10.1186/s12943-020-01186-6.
10
Verbascoside inhibits progression of glioblastoma cells by promoting Let-7g-5p and down-regulating HMGA2 via Wnt/beta-catenin signalling blockade.毛蕊花糖苷通过抑制 Wnt/β-catenin 信号通路阻断来促进 Let-7g-5p 的表达并下调 HMGA2,从而抑制神经胶质瘤细胞的进展。
J Cell Mol Med. 2020 Mar;24(5):2901-2916. doi: 10.1111/jcmm.14884. Epub 2020 Jan 30.
miR-1 和 miR-200 通过 Slug 依赖性和 Slug 非依赖性机制抑制 EMT 并促进肿瘤发生。
Oncogene. 2013 Jan 17;32(3):296-306. doi: 10.1038/onc.2012.58. Epub 2012 Feb 27.
4
miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells.miR-200a 调节乳腺上皮细胞中的 SIRT1 表达和上皮间质转化(EMT)样转化。
J Biol Chem. 2011 Jul 22;286(29):25992-6002. doi: 10.1074/jbc.M111.229401. Epub 2011 May 19.
5
Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis HMGA2 as a prognostic marker of bladder cancer.高迁移率族蛋白 A2 在膀胱癌中的过表达及其与临床病理特征和预后的关系 高迁移率族蛋白 A2 作为膀胱癌的预后标志物。
Eur J Surg Oncol. 2011 Mar;37(3):265-71. doi: 10.1016/j.ejso.2011.01.004. Epub 2011 Jan 26.
6
Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers.HMGA2 的过表达促进结直肠癌的转移并影响其生存。
Clin Cancer Res. 2011 Apr 15;17(8):2570-80. doi: 10.1158/1078-0432.CCR-10-2542. Epub 2011 Jan 20.
7
HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes.高迁移率族蛋白A2(HMGA2)过表达诱导的卵巢表面上皮转化是通过对上皮-间质转化(EMT)相关基因的调控介导的。
Cancer Res. 2011 Jan 15;71(2):349-59. doi: 10.1158/0008-5472.CAN-10-2550. Epub 2011 Jan 11.
8
MiR-30 family and EMT in human fetal pancreatic islets.miR-30 家族与人类胎儿胰岛中的 EMT
Islets. 2009 Nov-Dec;1(3):283-5. doi: 10.4161/isl.1.3.9968.
9
The basics of epithelial-mesenchymal transition.上皮-间质转化的基础知识。
J Clin Invest. 2009 Jun;119(6):1420-8. doi: 10.1172/JCI39104.
10
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.